Management of Overweight during Childhood: A Focus Group Study on Health Professionals' Experiences in General

Lone Marie Larsen1, Loni Ledderer2, Dorte Ejg Jarbøl3

  • 1Hans Christian Andersen Children's Hospital, Odense University Hospital, 5000 Odense C, Denmark.

Insights

General practitioners and nurses feel responsible for managing childhood obesity, but face barriers. Future programs need to address these challenges beyond standardized strategies for better childhood overweight management.

Area of Science:

  • Pediatrics
  • General Practice
  • Public Health

Background:

  • Rising prevalence of childhood overweight and obesity in Western countries.
  • Increased focus on management strategies within general practice settings.

Purpose of the Study:

  • To explore the experiences of general practitioners (GPs) and practice nurses in a randomized controlled trial (RCT) for childhood overweight/obesity management.
  • To identify perceived responsibilities, challenges, and facilitators in managing pediatric obesity in primary care.

Main Methods:

  • Qualitative study utilizing three focus groups with GPs and practice nurses involved in an RCT.
  • Systematic text condensation followed by thematic analysis of transcribed data.

Main Results:

  • Healthcare professionals acknowledged their responsibility and the complexity of managing childhood overweight, emphasizing the need for evidence-based, supervised strategies.
  • Barriers to addressing childhood obesity were experienced, yet increased societal awareness of obesity facilitated understanding and approaches.
  • GPs and nurses recognized their unique role and capacity in pediatric obesity management.

Conclusions:

  • General practice professionals have a distinct obligation and capability in managing childhood obesity.
  • Future management programs must overcome identified barriers and extend beyond standardized, evidence-based approaches to be effective.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
343
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
394
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
287
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
344
Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
2.7K